Acasti Pharma Inc. (ACST) shares were rising 22.04% to trade at $0.659 in after-hours at last check. As of the last check, shares of Ascasti Pharma Inc. (ACST) had risen 22.04% to $0.659 in after-hours trading. On Tuesday, Acasti stock closed at $0.54, up 10.20% from the previous close. Volume for Acasti stock increased to […]
Why Acasti (ACST) Stock Rose 22% In After Hours Trades? Read More »
Valaris Limited (VAL) shares gained 5.93% in after-hours on Tuesday, June 22, 2021, and closed the day at $30.00 per share. Earlier in the morning session, VAL’s stock gained 0.04% to close Tuesday’s session at $28.32 per share. VAL shares have moved up by 2.91% in the past week. Further, the company has a current
Here is why Valaris Limited (VAL) stock performed well on Tuesday? Read More »
Gemini Therapeutics Inc. (GMTX) shares collapsed 35.01% in after-hours on Tuesday, June 22, 2021, and closed the day at $6.35 per share. Earlier in the morning session, GMTX’s stock lost 4.50% to close the session at $9.77 per share. GMTX shares have moved down 8.43% in the past week. Over the past three months, the
Why Gemini Therapeutics Inc (GMTX) stock slid down on Tuesday? Read More »
BioXcel Therapeutics Inc. (BTAI) stock started the Tuesday, June 22, 2021, trading by losing 3.63% in the morning session and closed at $36.85 per share. The decline continued in the after-market session and BTAI shares further plunged 8.06% and closed the day at $33.88 per share. BTAI shares have fallen 35.32% over the last 12
Here is why BioXcel Therapeutics Inc. (BTAI) underperformed on Tuesday? Read More »
Second Sight Medical Products Inc. (EYES) shares lost 14.80% in after-hours on Tuesday, June 22, 2021, and closed at $5.41 per share. Earlier, EYES’s stock lost 1.40% to close Tuesday’s normal session at $6.35 per share. EYES shares have risen 482.57% over the last 12 months, and they have moved down 4.01% in the past
Why Second Sight Medical Products Inc. (EYES) stock faced headwinds on Tuesday? Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.